PRESS RELEASES

(this item is regulatory) Dignitana secures SEK 10 million line of credit from largest shareholder

Dignitana announces American Medical Association reaffirms policy supporting scalp cooling

(this item is regulatory) Bulletin from the annual general meeting of Dignitana AB (publ)

(this item is regulatory) Kommuniké från årsstämma i Dignitana AB (publ)

(this item is regulatory) Dignitana AB Publishes Q1 2022 Interim Report

(this item is regulatory) Dignitana AB appoints Chief Financial Officer

(this item is regulatory) Dignitana AB publishes Annual Report for 2021

(this item is regulatory) Dignitana AB publicerar Årsredovisningen för 2021

(this item is regulatory) KALLELSE TILL ÅRSSTÄMMA i Dignitana AB (publ)

(this item is regulatory) NOTICE OF ANNUAL GENERAL MEETING IN Dignitana AB (publ)

Dignitana Publishes Spring Newsletter

(this item is regulatory) Dignitana AB Publishes Q4 2021 Interim Report

(this item is regulatory) Dignitana AB appoints Interim CFO

Dignitana kicks off 2022 with Susan G. Komen[®] Orlando event

Dignitana to address Stockholm Corporate Finance Life Science Seminar

(this item is regulatory) Dignitana utser Catarina Mård Löwenadler till VD

(this item is regulatory) Dignitana appoints Catarina Mård Löwenadler as CEO

(this item is regulatory) Magnus Blixt to become CEO of Dignitana AB

(this item is regulatory) William Cronin to resign as CEO of Dignitana AB

(this item is regulatory) William Cronin lämnar som VD för Dignitana AB

Dignitana publishes December newsletter

Dignitana AB Appoints Nomination Committee

Dignitana CEO William Cronin to address company growth and reimbursement at Erik Penser Bank’s Bolagsdag

(this item is regulatory) Dignitana AB Publishes Q3 2021 Interim Report

(this item is regulatory)Dignitana Announces Decision by Medicare to Reassign Payment for Scalp Cooling

Dignitana honors young breast cancer survivor Maricel Otero as a DigniCap Dignitary

Dignitana publishes October newsletter

Dignitana kicks off Breast Cancer Awareness Month with Susan G. Komen[®] sponsorship

Dignitana Honors Nikki Cox as a DigniCap Dignitary

Dignitana Honors Carla Thomas Cavalier as a DigniCap Dignitary

(this item is regulatory) Dignitana AB meddelar att CFO kommer att lämna företaget

(this item is regulatory) Dignitana AB announces CFO will leave the Company

Dignitana Names Colorado Mom and Breast Cancer Survivor as a DigniCap Dignitary

Dignitana Honors Melanie Waxler as a DigniCap Dignitary and Host of a New Interview Series

Dignitana publishes September newsletter

Dignitana Honors Ovarian Cancer Survivor as a “DigniCap Dignitary”

(this item is regulatory) Dignitana AB Publishes Q2 2021 Interim Report

Dignitana signs distributor B&Co Group to support Benelux Growth

Dignitana publishes July newsletter

Dignitana launches new initiatives to support reimbursement and market access

Dignitana publishes June newsletter

Dignitana CEO William Cronin to speak at Småbolagsdagarna 2021

(REGULATORY) Bulletin from the Annual General Meeting of Dignitana AB (publ)

(REGULATORY) Dignitana AB Publishes Q1 2021 Interim Report

(REGULATORY) Kommuniké från årsstämma i Dignitana AB (publ)

Dignitana-backed insurance legislation clears Texas House committee

Dignitana publishes April newsletter

(REGULATORY) Kallelse till årsstämma i Dignitana AB (publ)

(REGULATORY) Notice of Annual General Meeting in Dignitana AB (Publ)

(REGULATORY) Dignitana AB publicerar Årsredovisningen för 2020

Dignitana to address Stockholm Corporate Finance Life Science Seminar on March 24

Dignitana publishes March newsletter

Dignitana expands agreement with GenesisCare to include United States

(REGULATORY) Rättelse: Dignitana AB Bokslutskommuniké 2020

(REGULATORY) Dignitana AB Bokslutskommuniké 2020

(REGULATORY) Dignitana AB Publishes 2020 Year End Report

Dignitana publishes January newsletter

(REGULATORY) Correction: Bulletin from the Extraordinary General Meeting in Dignitana AB (publ)

(REGULATORY) Rättelse: Kommuniké från extra bolagsstämma i Dignitana AB (publ)

(REGULATORY) Bulletin from the Extraordinary General Meeting in Dignitana AB (publ)

(REGULATORY) Kommuniké från extra bolagsstämma i Dignitana AB (publ)

2021 kicks off with positive developments for Dignitana AB

Mammazentrum Hamburg selects DigniCap Delta for upgraded scalp cooling therapy

(REGULATORY) Correction: Notice to attend Extraordinary General Meeting in Dignitana AB

(REGULATORY) Rättelse: Kallelse till extra bolagsstämma i Dignitana AB

(REGULATORY) Notice of Extraordinary General Meeting in Dignitana AB (publ)

(REGULATORY) Kallelse till extra bolagsstämma i Dignitana AB (publ)

(REGULATORY) Dignitana announces directed share issue of SEK 75 million to accelerate growth and strategic transition to DigniCap Delta, and write-down of an older generation of devices.

(REGULATORY) Dignitana offentliggör riktad nyemission om 75 miljoner kronor för accelererad tillväxt och den strategiska övergången till DigniCap Delta, samt nedskrivning av en äldre generation maskiner.

(REGULATORY) GenesisCare selects Dignitana as preferred scalp cooling provider for its rapidly expanding Australia medical oncology centres

(REGULATORY) Dignitana AB Publishes Q3 2020 Interim Report

(REGULATORY) Dignitana publicerar kvartalsrapport för Q3 2020

Dignitana publishes November newsletter

(REGULATORY) New CPT Codes for Mechanical Scalp Cooling Support Pathway to Reimbursement in the U.S.

(REGULATORY) Ny CPT-koder för mekanisk skalpkylning banar väg för ersättning i USA

Dignitana publishes October newsletter

Cancer leader City of Hope selects DigniCap for community network in California

Dignitana Signs Agreement with ION Solutions

Dignitana publishes September newsletter

Dignitana AB to present at September 10[th] Investor Forum Online

(REGULATORY)Dignitana AB Publishes Q2 2020 Interim Report

(REGULATORY) Dignitana publicerar kvartalsrapport för Q2 2020

Dignitana publishes August newsletter

Dignitana expands European focus with new Regional Director

Dignitana förstärker europeiskt fokus med ny Regional Director

(REGULATORY) Dignitana AB appoints new Chief Financial Officer

(REGULATORY) Dignitana AB utser ny Chief Financial Officer

(Regulatory) Dignitana AB changes Certified Adviser to Redeye AB

(Regulatory) Dignitana AB byter Certified Adviser till Redeye AB

(Regulatory) Dignitana strengthens operating capital through a loan from Adma Förvaltnings AB

(Regulatory)Dignitana stärker rörelsekapitalet genom ett lån från Adma Förvaltnings AB

Dignitana selected as Scalp Cooling Provider by Nuffield Health in UK

Dignitana publishes July newsletter

Dignitana adds five more contracts under AON agreement

(Regulatory)Dignitana: Resolutions from the Annual General Meeting on 25 June 2020

(Regulatory)Dignitana: Beslut vid årsstämman den 25 juni 2020

Dignitana publishes June newsletter

 (REGULATORY) Dignitana AB Publishes Q1 2020 Interim Report

 (REGULATORY) Dignitana publicerar kvartalsrapport för Q1 2020

Dignitana signs master contract with American Oncology Network

Dignitana AB announces two presentations for shareholders

(REGULATORY) NOTICE OF ANNUAL GENERAL MEETING IN DIGNITANA AB (publ)

(REGULATORY) KALLELSE TILL ÅRSSTÄMMA i DIGNITANA AB (publ)

Dignitana Publishes May Newsletter

(REGULATORY) Dignitana publishes Annual Report 2019

(REGULATORY) Dignitana publicerar Årsredovisning 2019

(REGULATORY) Dignitana AB strengthens financial position with new loan

(REGULATORY) Dignitana receives loan from COVID-19 US stimulus package

Dignitana signs master contract with Hartford HealthCare

Dignitana to participate in Redeye Medtech & Diagnostics Seminar on May 5

Dignitana medverkar på Redeye Medtech & Diagnostics Seminar den 5 maj

(REGULATORY) Dignitana announces new date for AGM and postpones publication of 2019 Annual Report

(REGULATORY) Dignitana meddelar nytt datum för årsstämma och offentliggörande av årsredovisning 2019

Dignitana to present business update related to COVID-19 this Thursday

Dignitana Publishes March Newsletter

Dignitana launches DigniCap Mobile App to support patient-centered care

Dignitana to participate in Stockholm Corporate Finance 12[th] Life Science Seminar on March 12

Dignitana medverkar på Stockholm Corporate Finance 12:e Life Science-seminarium den 12 mars

(REGULATORY) Dignitana AB Year End Report 2019

(REGULATORY) Dignitana AB Bokslutskommuniké 2019

Dignitana signs MedPhy Technologies as DigniCap distributor in India

Dignitana Publishes February Newsletter

Dignitana to sponsor Susan G. Komen[® ]events in Dallas, New York and Los Angeles

(REGULATORY) Dignitanas extra bolagsstämma

Dignitana innovation recognized at Arab Health Conference

Dignitana Publishes January Newsletter

NOTICE OF EXTRAORDINARY GENERAL MEETING IN DIGNITANA AB (publ)

KALLELSE TILL EXTRA BOLAGSSTÄMMA i DIGNITANA AB (publ)

2019-12-12 Dignitana Publishes December Newsletter

2019-11-19 (REGULATORY) Dignitana AB Publishes Q3 2019 Interim Report

2019-11-19 (REGULATORY) Dignitana publicerar kvartalsrapport för Q3 2019

2019-11-14 Dignitana Publishes November Newsletter

2019-11-13 Invitation to Presentation of Dignitana’s Third Quarter Interim Report

New Contracts Support Global Expansion for Dignitana

2019-10-10 Dignitana Publishes October Newsletter

2019-09-19 Dignitana receives TGA approval for DigniCap Delta scalp cooling system in Australia

2019-09-12 Dignitana Publishes September Newsletter

2019-09-10 Dignitana appoints DigniCap Dignitary with focus on ovarian cancer advocacy

2019-09-09 Dignitana introduces new scalp cooling technology to Southern California

2019-09-04 Dignitana sponsors Italian short film for Venice Film Festival 2019

2019-09-02 (REGULATORY) Dignitana receives SEK 42 million in a directed new issue of units
(REGULATORY) Dignitana tillförs 42 miljoner SEK i en riktad nyemission av units
2019-08-30 (REGULATORY) Dignitana avser att genomföra en riktad nyemission av units
2019-08-30 (REGULATORY) Dignitana intends to make a directed new issue of units
2019-08-22 (REGULATORY) Delårsrapport Q2 2019
2019-08-22 (REGULATORY) Dignitana AB Publishes Q2 2019 Interim Report
2019-08-12  Dignitana delivers first DigniCap Delta in United States
2019-08-01 Dignitana AB Publishes August Newsletter
Dignitana signs Atrium Health in U.S. for DigniCap Delta scalp cooling system
(REGULATORY) Dignitana receives FDA clearance for DigniCap Delta scalp cooling system
(REGULATORY) Dignitana får FDA-godkännande i USA för DigniCap Delta scalp cooling system
2019-06-20  Dignitana AB Publishes June Newsletter
2019-06-17  Dignitana installs the first DigniCap Delta Scalp Cooling System in Rome
2019-05-22 Dignitana Promotes Scalp Cooling at Supportive Care Conference
2019-05-17 Dignitana AB Publishes May Newsletter
Communication from the Dignitana AB Annual General Meeting 2019
Kommuniké från Dignitana AB årsstämma 2019
(REGULATORY) Dignitana AB Publishes Q1 2019 Interim Report
2019-05-13 Dignitana Leadership Efforts Prompt Landmark Legislation
Dignitana Publishes April Newsletter
2019-04-16 Notice of Annual General Meeting of Dignitana AB (publ)
2019-04-16 Kallelse till årsstämma i Dignitana AB (publ)
2019-04-12 (REGULATORY) Correction: Incorrect MAR Classification in previous press release
(REGULATORY) Rättelse: Felaktig MAR-klassificering i tidigare pressmeddelande
(REGULATORY) Dignitana AB Publishes Annual Report for 2018
(REGULATORY) Dignitana AB publicerar årsredovisningen för 2018
2019-03-27 (REGULATORY) Dignitana AB Receives CE Marking for Next Generation DigniCap Delta to Reduce Hair Loss from Chemotherapy
2019-03-14 Dignitana CEO William Cronin to Speak at Aktiedagen Stockholm
2019-03-13 Dignitana AB Publishes March Newsletter
Dignitana AB Taps oneservice as Service Provider in Europe
2019-02-26 (REGULATORY) Dignitana AB Publishes Year End Report for 2018
(REGULATORY) Dignitana AB Publishes February Newsletter
(REGULATORY) Amendment – Last day of trading of paid-up shares in Dignitana AB (publ) is today, the 29 of January 2019
(REGULATORY) Last day of trading of paid-up shares in Dignitana AB (publ)
(REGULATORY) Rättelse – sista dag för handel med BTA i Dignitana AB (publ) är idag den 29 januari 2019
(REGULATORY) Sista dag för handel med BTA i Dignitana AB (publ)
Dignitana AB Publishes January Newsletter